-
Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
-
Contineum Therapeutics (CTNM) PT Raised to $32 at RBC Capital
-
RBC Capital Starts Contineum Therapeutics (CTNM) at Outperform
-
Contineum Therapeutics (CTNM) Announces 8.8M Share IPO at $16-$18/sh
-
Contineum Therapeutics (CTNM) Announces Proposed IPO

